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monthly interval for blood pressure and heart rate and proteinuria
was assessed at six month.
Results: Both the groups were well matched in term of sex, age,
and weight. Both cilnidipine and amlodipine significantly reduced
both systolic and diastolic blood pressure. Pulse rate were higher
in patient treated with amlodipine than the patient treated with
cilnidipine. Cilnidipine decreased proteinuria which was not seen
in patient on amlodipine.
Conclusion: Thus, study showed that cilnidipine which is Land N
type calcium channel inhibitor is better than amlodipine which L
type of calcium channel inhibitor in patient having cardiovascular
disease, diabetes and renal disease and is better alternative to
amlodipine.
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Background: Complete Heart Block (CHB) is a condition in which
the impulse generated in the SA node does not propagate to the
ventricles. Causes include coronary ischemia, idiopathic degen-
eration of AV node and others. Symptomatic patients were
advised Permanent pacemaker insertion. Most have high blood
pressure as per Marey’s law (1961).
Aim: To assess the effect of permanent pacing VVI mode in CHB
patients on central systolic pressure, pulse pressure and arterial
stiffness and to assess the effect of vasodilator therapy in reducing
arterial stiffness in CHB patients on Permanent pacing VVI mode.
Methods: This study is a prospective analytical study done in
Department of Cardiology at single-centre tertiary care hospital
setting from January 2014 to July 2014. 18 consecutive patients
with CHB before and after permanent pacemaker (VVI mode)
insertion were included. Baseline characteristics like Brachial
Systolic Blood Pressure (SBP), Central SBP, Central pulse pressure
(PP), Augmentation pressure (AP), Augmentation Index(AI) and
Heart Rate were measured before and 10 days after pacemaker
insertion. Brachial SBP was measured with Sphygmomanometer
and Central Pressure and stiffness measured using Sphygmocor
device (Excel) which derives central parameters by FDA approved
transfer function. Data were presented as mean ± 1SD and the
characteristics were compared using t test. A p value of less than
0.05 was considered statistically significant. Diabetic patients
were excluded from study.
Results: Out of 18 Patients, mean age was 59yrs (lowest 27yrs and
highest 80yrs), 11 were males and 7 were females.
Conclusion: Insertion of Permanent Pacemaker Insertion VVI
mode shows significance reduction in Central systolic pressure
and arterial stiffness. Based on Central Blood Pressure and Arterial
stiffness assessment some patient needed vasodilators to reduce
arterial stiffness after Permanent pacing.
Use of angiotensin receptor blockers for the
treatment of hypertension in India
H.S. Malhi
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Background: ARBs have been included as a first-line therapy in JNC
8. Additionally, the 2014 ASH/ISH guidelines recommend that ARBs
shouldbepreferredoverACE-I if theyareavailable andaffordable as
they do not cause cough and only rarely cause angioedema, and
haveeffects andbenefits similar toACE-I.Currently there isadearth
of data regarding the use of ARBs as monotherapy or combination
therapy for the treatment of hypertension in India.
Methods: A prescription research survey was conducted amongst
physicians in India to obtain insights about the use of ARBs and
their combinations in clinical practice. The study was conducted
through a survey questionnaire consisting questions on use of
ARBs as an antihypertensive, including preferences of molecules
amongst the ARBs and the combinations of ARBs used for the
management of hypertension with/without comorbid conditions.
Results: The survey questionnaire was answered by 409 physi-
cians. ARBs are preferred as the first-line antihypertensive in
Baseline After treatement
Amlodepine(n-24) Cilnidipine(n-26) Amlodepine(n-24) Cilnidipine(n-26)
Age yrs 58+-4 62+-5
BMI 26+-4 24+-2.6
Number with DM 12 14
Number with proteinuria 10 12
Day time SBP 164+-12 166+-14 152+-10 154+-11
Day time DSP 96+-8 100+-10 88+-8.4 91+-6.2
Day time PR 74+-9.8 72+-7.2 78+-7 64+-4
Night time SBP 140+-18 144+-16 132 +-12 136+-10
Night time DBP 92+-6.4 94+-8.4 88+-6 90+-8
Night time PR 60+-7 64+-8.4 66+-14 60+-8
Characteristics Pre Post PPI P Value
Brachial SBP 157 ± 18.6 122.8 ± 16.96 <0.0001
Central SBP 143 ± 14.37 111 ± 14.53 <0.0001
Central PP 63.9 ± 16 38.11 ± 11 <0.0001
AP 21.56 ± 7.22 10.22 ±5.73 <0.0001
Al 41.4 ± 9.16 24.05 ± 9.9 <0.0001
Pre PPI Pre Brachial VS Central SBP <0.05
Post PPI Post Brachial VS Central SBP <0.04
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newly-diagnosed patients by 84% respondents. A similar per-
centage of the doctors (85%) preferred olmesartan over the other
ARBs. Ninety percent of the doctors responded that olmesartan
provided both “rapid control of BP” and “maximum reduction of
BP” in comparisonwith the other ARBs. In patients with T2DM and
nephropathy ~70% doctors prefer olmesartan over the other sar-
tans. Additionally, the triple drug combinations of olmesartan
were preferred over the triple drug combinations of telmisartan.
Conclusions: This survey has demonstrated that Indian doctors
use ARBs as a first-line antihypertensive, which is supported by
the recent guidelines. Amongst the ARBs, olmesartan is preferred
for the treatment of hypertension and is associated with the
properties of prompt reduction of BP and strong reduction of BP.
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Background: Microalbuminuria is a powerful predictor of cardio-
vascular events and is considered as target organ damage in pa-
tients with essential hypertension. The purpose of the present
study was to explore the effect of current smoking on micro-
albumin excretion in patients with essential hypertension.
Methods: The study comprised 200 consecutive patients with
essential hypertension who visited our outpatient clinic from
-2013 TO 2014. All patients underwent full clinical, laboratory and
screening evaluation. Patients under treatment followed a wash-
out period at least for 15 days. All subjects underwent a 24hour
urine sample collection and thus microalbumin, albumin-crea-
tinin ratio (ACR) and 24h creatinin clearance were measured.
Smoking habits were assessed by means of a standard
questionnaire.
Results: Patients were divided in two groups according to their
current smoking habits: group I (n¼127 non-smokers) and group II
(n¼73 smokers). Smokers were younger (P¼0.001), had higher
diastolic blood pressure (DBP) (P<0.001), greater microalbumin
levels (P<0.001), higher ACR (P<0.001) and higher body mass index
(BMI) (P¼0.03) compared to non-smokers. The two groups had no
differences in systolic blood pressure (SBP), renal hemodynamics,
glucose levels and 24h creatinin clearance (P¼NS). After multi-
variate analysis was performed smoking remained significant
determinant of higher ACR and microalbumin levels (P<0.0001)
independently of DBP, BMI and age.
Conclusions: Smoking is associated with greater microalbumin
excretion in patients with essential hypertension. Thus smoking
may pose a burden to renal function in these subjects.
Long-term follow-up results of renal angioplasty
in Takayasu arteritis
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Background: Takayasu arteritis (TA) with stenosis of renal arteries
frequently presents with hypertension in young adults.
Angioplasty of these lesions is expected to control hypertension
and renal damage. We present the long term results of renal an-
gioplasty done over 5 years in our hospital.
Methods: All cases of Takayasu arteritis that underwent renal
angioplasty from 2006 to 2011 were followed up clinically and by a
renal Doppler in all cases. A cine renal- angiogram was advised at
6 months and 18 month visit. We performed renal angioplasty in
56 lesions (48 patients; 34 females; age range 22 to 46 years; mean
28.5±4.65 years). Unilateral lesions were seen in 40 patients and
rest had one lesion in each renal artery. Of them 34 cases with at
least 24 months follow-up data were included for analysis.
Results: Technical success rate was 89.3 %( 50/56) lesions with no
MACE at 30 days. Of the 6 failure cases one with bilateral lesions
was sent for emergency surgery due to renal artery rupture
following PTRA. The 3 of the rest 5 underwent elective surgical
revascularization. On a mean follow up of 26.5±8.5months, 12 of
34 cases (14 of 37 lesions (37.8%) developed restenosis and 10 of
them were successfully redilated. There was death of one patient
with bilateral lesions due to CRF.
Cure of hypertension (BP <140/90 mmHg without need for
medication) and improvement (BP<140/90 mmHg with same or
reduced number ofmedications) was achieved in 12/34(35.3%) and
10/34(29.4%) respectively. Of the 15 cases with raised serum
Creatinine7/15 (49.7%) had shown a fall in their values in follow-
up (mean 1.71± 1.05mg to 1.1±0.76 mg; p-<0.005)
Conclusion: While acute results were satisfactory, the restenosis
was seen in about one-third of the cases after an initial successful
procedure most of which could be redilated. Control of hyperten-
sion and renal dysfunction was achieved in a significant number.
Antihypertensive effect of rosuvastatin in
normocholesterolemic hypertensive patients and
its association with flow mediated dilation and
oxidative stress
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Background: Hypertension is one of the most important contrib-
utors to heart disease and stroke which together make up the
world’s number one cause of premature death and dis-
ability.Since the time statins have been introduced,several pleio-
tropic effects of statins that have been described.In the past few
years ,another effect of statins has been proposed that statinsmay
also lower blood pressure and thus act through a reduction in the
blood pressure related risk. Because endothelial dysfunction plays
a significant role in the pathogenesis of arterial hypertension, it is
reasonable to search for new strategies aimed at improving
endothelial function.
Aim: To study the effect of rosuvastatin therapy in normocho-
lesterolemic patients when added to antihypertensive agent on: a)
Blood pressure in stage 1 hypertensive individuals.b)Endothelial
functionand oxidative stress levels in stage 1 hypertensive
individuals.
Methods: It was a randomized double blind study conducted over
a period of 1year. Total 100 cases of stage 1 hypertensive normo-
cholesterolemic subjects who were not on any lipid lowering drug
were recruited and divided into two groups: Group A (antihyper-
tensive agent+rosuvastatin) and Group B (antihypertensive
agent+placebo). The patients were followed up every two weeks
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